GSK Short Volume

GSK plc (GSK) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry, with a market capitalization near $92.70B, listed on NYSE, employing roughly 66,841 people, carrying a beta of 0.28 to the broader market. GSK plc, a global pharmaceutical entity founded in 1715 and headquartered in Brentford, United Kingdom, dedicates its efforts to the research, development, and manufacturing of a wide array of medical solutions. Led by Luke Victor Miels, public since 1980-03-28.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date
2026-10-14
Short Volume
1.3M
Total Volume
3.5M
Short %
36.61%
30-Day Avg Short %
44.95%

Showing 30 days of FINRA short volume data for GSK plc.

Learn how short volume is reported and how to read the data →

Frequently asked GSK short volume questions

What is the daily GSK short volume?
As of Oct 14, 2026, GSK plc (GSK) short volume is 1.3M shares against 3.5M total reported volume, or 36.61% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
How is GSK short volume reported?
FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
What does GSK short volume tell options traders?
Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.